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Abstract— Dynamic contrast-enhanced ultrasound (DCE-US) is highly 
susceptible to motion artifacts arising from patient movement, respiration, 
and operator handling and experience. Motion artifacts can be especially 
problematic in the context of perfusion quantification. In conventional 2D 
DCE-US, motion correction algorithms take advantage of accompanying 
side-by-side anatomical Bmode images that contain time-stable features. 
However, current commercial models of 3D DCE-US do not provide side-
by-side Bmode images, which makes motion correction challenging. This 
work introduces a novel motion correction (MC) algorithm for 3D DCE-
US and assesses its efficacy when handling clinical data sets. In brief, the 
algorithm uses a pyramidal approach whereby short temporal windows 
consisting of 3-6 consecutive frames are created to perform local 
registrations, which are then registered to a master reference derived from 
a weighted average of all frames. We evaluated the algorithm in 8 patients 
with metastatic lesions in the liver using the Philips X6-1 matrix transducer 
at a frame rate of 1-3 Hz. We assessed improvements in original vs. motion 
corrected 3D DCE-US cine using: i.) frame-to-frame volumetric overlap of 
segmented lesions, ii.) normalized correlation coefficient (NCC) between 
frames (similarity analysis), and iii.) sum of squared errors (SSE), root-
mean-squared error (RMSE), and r-squared (R2) quality-of-fit from fitted 
time-intensity curves (TIC) extracted from a segmented lesion. Overall, 
results demonstrate significant decreases in 3D DCE-US motion after 
applying the proposed algorithm. We noted significant improvements in 
frame-to-frame lesion overlap across all patients, from 68%±13% without 
correction to 83%±3% with motion correction (p = 0.023). Frame-to-frame 
similarity as assessed by NCC also significantly improved on two different 
sets of time points from 0.694±0.057 (original cine) to 0.862±0.049 
(corresponding MC cine) and 0.723 ±0.066 to 0.886 ±0.036 (p ≤ 0.001 for 
both). TIC analysis displayed a significant decrease in RMSE (p = 0.018) 
and a significant increase in R2 goodness-of-fit (p = 0.029) for the patient 
cohort.  
 
Index Terms— Contrast-enhanced (CE), motion correction 
(MC), three-dimensional (3D), ultrasound (US) 
I. INTRODUCTION 
The introduction of contrast-enhanced ultrasound 
imaging has significantly expanded the diagnostic 
potential of ultrasound as a non-invasive and 
inexpensive imaging modality (1). Imaging tissue 
perfusion is feasible using dynamic contrast-
enhanced ultrasound (DCE-US) methods in 
contrast-mode to isolate contrast signal from tissue 
signals in several abdominal indications, as well as 
other anatomical sites accessible to ultrasound, and 
has been adopted in global clinics for over a decade 
now (2). While both CT and MRI imaging 
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modalities also offer contrast-enhanced tissue 
perfusion measurements, ultrasound-based contrast 
imaging is advantageous clinically because it is 
inexpensive relative to other imaging modalities, 
without radiation, available at the bedside, and 
offers a uniquely intravascular contrast agent that 
does not leak out of tumor permeable vessels.  More 
recently, three-dimensional (3D) DCE-US was 
introduced with the availability of contrast-mode 
imaging on commercially-available clinical matrix 
transducers. 3D DCE-US offers volumetric imaging 
that minimizes sampling errors and operator-
influence on quantification; this is particularly 
important in longitudinal imaging applications such 
as cancer treatment monitoring (3). In contrast, 
imaging tumors via conventional 2D DCE-US is 
prone to sampling errors and can produce biased 
quantitative results because of plane-to-plane 
perfusion variation and tumor heterogeneity (4). 3D 
DCE-US imaging mitigates these errors by imaging 
the tumor as a whole through dynamic volumetric 
images (5). 
 
Several quantification techniques have been 
introduced to characterize tissue perfusion 
properties from DCE-US imaging studies (1-6). 
Perfusion changes, which can be quantified 
longitudinally using CE-US methods, are indicative 
of both disease type and treatment response (7-10). 
However, the quality of quantification is affected by 
several imaging and clinical limitations. In 
particular, ultrasound-based dynamic imaging is 
highly susceptible to motion artifacts arising from 
patient movement, respiration, and peristalsis, as 
well as operator hand stability (11). Motion artifacts 
can be especially hampering in lengthy acquisitions 
and in the context of quantification by introducing 
significant errors to the quantified contrast signal. In 
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a study investigating the ability of conventional 2D 
DCE-US imaging to measure tumor response to 
targeted therapy in renal cell carcinoma patients, the 
investigators observed significant differences due to 
respiratory motion in perfusion parameters after 
bolus time-intensity analysis (6). Another study 
investigating ultrasound imaging of focal liver 
lesions encountered technical failures due to motion 
artifacts from patient movement (12). These studies 
have concluded that motion correction (MC) 
techniques that account for motion artifacts are 
essential for reliable usage of DCE-US imaging in 
cancer treatment monitoring (13).  
 
In conventional DCE-US, motion artifacts can 
originate from two sources - the respiratory cycle of 
patients being examined, and/or probe motion by 
the operator or the patient moving - the latter is 
especially challenging in longer scan sequences 
such as is often the case with contrast imaging 
where the probe can also drift out of the original 
target plane. In our use-case scenario, contrast-cine 
in 3D last 3-10 min (bolus or infusion) [REF]. A 
common approach to mitigate motion is to ask the 
patient to breath-hold, however, this only reduces 
respiratory motion in roughly the first 5-20 seconds 
of a cine sequence, and depends largely on a 
patients’ ability to hold breath; breath hold can also 
introduce large motion artifacts when the patient 
resumes breathing with a large breath. Several 
gating techniques have also been reported to focus 
quantification only on frames within the same 
respiratory cycle [REF]; however, gating is non-
ideal in quantification approaches as it reduces the 
temporal resolution of contrast kinetics. This is 
especially challenging with current clinical 
implementation of 3D DCE-US where the frame 
rate is already below 3 Hz. Gating can also be time 
consuming if done manually, and does not eliminate 
non-cyclic motion (i.e. operator or patient direct 
movements). 
 
Commercial software solutions such as Qvue or 
[BRACCO software] offer a suite of quantification 
tools that include motion correction; these tend to 
rely on side-by-side Bmode images available in 2D 
DCE-US, and lock in on stable image features in the 
Bmode data to register all frames back to a 
reference frame [REF]. However, it is important to 
note that none of the clinically available 
commercial implementations of 3D DCE-US 
currently offer a side-by-side Bmode. Several novel 
motion correction algorithms for DCE-US have 
been developed that do not rely on Bmode data, and 
instead require modelling of the contrast flow from 
the TIC, and noise signal within an ROI 
[REF:Barros papers]. Nonetheless, while incredibly 
promising, these are mainly designed with 2D 
imaging in mind, and are heavily limited by out-of-
plane motion, despite attempts to minimize these 
during acquisition or through gating, especially in 
non-cyclic conditions [REF: 13-14]. In 3D, one can 
utilize adapted registration methods and enable the 
use of more flexible transform space to improve 
motion correction, all while designing algorithms 
for the current limitations of 3D DCE-US 
implementations that include: 1) lack of side-by-
side Bmode, and 2) low frame rate.  
 
An inability to implement out-of-plane MC is not 
an issue with 3D DCE-US studies, however, no 
such side-by-side Bmode images are available in 
current commercial implementations of 3D DCE-
US imaging. This lack of anatomical accompanying 
Bmode images pose a challenge for using stable 
anatomical features as a reference for registration 
and motion compensation. Additionally, the 
relatively slow frame rates (compared to 2D 
imaging) (4) and highly dynamic nature of 
microbubble-contrast agents as they wash-in and -
out makes it very challenging to register subsequent 
frames to one another based off of proximity in 
time. The need for MC in DCE-US is especially 
important in quantitative clinical applications where 
perfusion parameters are used to measure relative 
changes in blood flow (i.e. treatment monitoring) 
(15) and more so when parametric maps of 
perfusion parameters are being generated on a 
voxel-by-voxel basis. The importance of MC in a 
voxel-by-voxel quantification setting was observed 
when we analyzed our clinical data and noticed that 
single voxel noise artifacts significantly affects 
voxel-wise parametric map generation and 
decreases time-intensity curve quality.  
 
In this paper, we detail the development of a 
novel MC algorithm for 3D DCE-US data 
unaccompanied by Bmode anatomical imaging that 
improves the reliability of bolus time-intensity 
analysis for perfusion parameters. We first describe 
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the details of the MC algorithm, and subsequently 
demonstrate its efficacy using 8 clinical data sets of 
liver metastasis 3D DCE-US imaging studies. To 
the best of our knowledge, no previous investigators 
have developed a MC algorithm for 3D DCE-US 
imaging of bolus microbubble injections. 
II. MATERIALS AND METHODS 
A. Clinical Case Analysis 
The MC algorithm was evaluated using eight 
human 3D-DCE US imaging studies of liver 
metastasis. All studies were approved by the 
Stanford University IRB. The imaging studies were 
acquired from patients who provided written 
consent, were 18 years of age or older, and 
presented with at least one liver metastasis that was 
within the range of 1-14 cm in diameter and 
confirmed using MRI/CT imaging studies. The 3D-
DCE US scanning was performed by an 
experienced sonographer using the commercial 
Philips X6-1 MHz xMATRIX array transducer at a 
setting of 1-3 Hz. Each original imaging study (pre-
MC) was processed using the algorithm to produce 
a motion corrected imaging study (post-MC).  
B. Positional Evaluation of MC Improvement 
In imaging studies affected by movement, the 
lesion often changes position within the 3D space 
captured by the transducer as a result of either 
patient or operator movement. In order to quantify 
the positional shift of the lesion from frame to 
frame, the lesions (tumors) were manually 
segmented using ITK-SNAP (18). Using MeVisLab 
(MeVis Medical Solutions, Version 3.0) 
quantification modules, the 3D lesion volume 
overlap was compared between frames within the 
sequence in order to determine the consistency of 
the lesion’s position pre-MC and post-MC. 
C. Similarity Evaluation of MC Improvement 
To determine whether MC resulted in a 
significant improvement that persisted throughout 
the entire imaging study, image similarity between 
neighboring frames was quantified within the 
imaging studies pre-MC and post-MC using 
normalized cross-correlation. 
D. Bolus Time-Intensity Evaluation of MC Improvement 
The presence of motion artifacts impairs the 
quality and reproducibility of quantitative data 
when generating time-intensity curves (TIC) for 3D 
DCE-US imaging studies. When motion artifacts 
are present, movement of the lesion of interest 
results in incorporation of noisy and irrelevant 
voxel intensity data into the TIC quantification 
software (19). Consequently, TIC data on tumor 
perfusion typically provides an inaccurate 
assessment of tumor response to cancer treatment. 
In order to evaluate improvement of TIC reliability, 
TICs were generated from the imaging studies pre-
MC and post-MC using an in-house quantification 
module written in MeVisLab (MeVis Medical 
Solutions, Version 3.0) and MATLAB (Math Inc., 
Version 9.4). The quality and reliability of the TIC 
was assessed by measuring the sum of squared 
errors (SSE), the root-mean-squared-errors 
(RMSE), and R2 values and comparing the values 
measured pre-MC and post-MC. 
 
 
Fig. 1. Outline of the MC Algorithm 
III. MC ALGORITHM DESCRIPTION 
The MC algorithm is based off of a two-pass 
window approach that relies on region-of-interest 
image masking, employs both affine and non-rigid 
image registration, and avoids the issue of 
variability between neighboring images biasing 
image registrations. Fig. 1 represents the schematic 
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of the algorithm, and Table I. defines the symbols 
used in the description of the algorithm. We utilized 
the NiftyReg open-source medical image 
registration software (16) and the FSL FMRIB 
Software Library for Imaging Analysis (17) in our 
implementation and executed the algorithm on the 
Stanford Sherlock Computing Cluster [Add 
reference].   
 
Each image acquisition represents a 4D cine 
consisting of 3D volumetric US image frames. In 
each imaging study, there are N image frames, I, 
comprising the video, 𝐼𝑛 ∈ {1,…,𝑁}.  All n images are 
used to create a master reference image for later 
use, A, that is the average of all the 3D image 
frames in the acquisition. The algorithm corrects 
images following microbubble injection. Since 
microbubble injection occurs at different frames for 
each acquisition, the algorithm determines the 
starting image frame, 𝐼𝑠, for MC by searching for 
the first image with a mean voxel intensity that 
exceeds XX% of the mean voxel intensity in 
baseline images; we manually verfied that the 
correct frame was selected for each data set. The 
images identified for MC, n∈{1,…,N-s}, are then 
divided into w short temporal windows of equal 
sizes, 𝑊𝑔 ∈ {1,…,𝐺}. Once the images have been 
categorized into specific windows, 𝐼𝑤
𝑛 , the images 
can then proceed to reference creation and image 
registration. The MC algorithm takes advantage of a 
series of affine and non-rigid image registrations 
between reference images and floating images 
(image that is restructured with respect to the 
reference image) in order to spatially realign and 
eliminate shape distortions within the images.  
 
1. First Pass:  
The first pass of image registration is intended to 
spatially realign and reshape the images with 
respect to the neighboring images within their 
respective windows. The initial image should 
ideally undergo a series of translations, rotations, 
resizing, shearing, and deformations that make it 
similar structurally and positionally to its 
neighboring images. Therefore, a window reference 
image, 𝑊𝑔, is created by averaging all the image 
frames comprising the window. The first pass of 
registrations begins with an affine registration of the 
images, 𝐼𝑔
𝑛, to their window average, 𝑊𝑔, in order to 
create a spatially realigned image, 𝐼𝑔
𝑛′. The image 
frame, 𝐼𝑔
𝑛′, then undergoes a non-rigid registration 
using the affine transformation, 𝑇𝑔
𝑛, as an 
initialization to create the final image product of the 
first pass, 𝐼𝑔
𝑛∅.  
 
 𝑇𝑔
𝑛 = 𝐴𝑓𝑓𝑖𝑛𝑒𝑅𝑒𝑔( 𝑊𝑔  , 𝐼𝑔
𝑛 )   (1.) 
 
  𝐼𝑔
𝑛∅ = 𝑁𝑜𝑛𝑅𝑖𝑔𝑖𝑑𝑅𝑒𝑔( 𝑊𝑔  , 𝐼𝑔
𝑛  ∘   𝑇𝑔
𝑛 )   (2.) 
 
2. Second Pass: 
The second pass’s purpose is to realign and 
reshape the image product of the first pass with 
respect to the entire imaging study. Since the first 
pass created a new series of images, a new window 
reference image, 𝑊𝑔′, is created by averaging all the 
newly transformed images within the window. The 
new window averages are then registered using an 
affine transform to the original master average, A, to 
create window averages, 𝑊𝑔
′𝑇, that are all spatially 
in sync with the average of the entire study. The 
second pass concludes with a non-rigid registration 
of the first pass image products, 𝐼𝑔
𝑛∅, to their final 
window averages, 𝑊𝑔
′𝑇. The products of the second 
pass, 𝐼𝑔
𝑛∅′,  should now be structurally and 
positionally similar to both images inside and 
outside their respective windows, thereby creating a 
motion corrected image study that occupies the 
same 3D space throughout the entire sequence. 
 
𝑇𝑔
𝑛′ = 𝐴𝑓𝑓𝑖𝑛𝑒𝑅𝑒𝑔( 𝐴  , 𝑊𝑔
′ )  (3.) 
 
𝑊𝑔
′𝑇 = 𝑊𝑔
′   ∘    𝑇𝑔
𝑛′   (4.) 
 
𝐼𝑔
𝑛∅
′
= 𝑁𝑜𝑛𝑅𝑖𝑔𝑖𝑑𝑅𝑒𝑔( 𝑊𝑔
′𝑇  , 𝐼𝑔
𝑛∅ )  (5.) 
 
TABLE I 
DESCRIPTORS FOR MC ALGORITHM 
Symbol Meaning 
I Image Frame 
n Frame’s time point in imaging acquisition 
N Number of frames in imaging acquisition 
A Imaging acquisition average 
s Starting frame for MC 
g Frame’s window group 
G Number of window groups 
W Window Average 
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T Affine transform 
∅ Non-Rigid deformation field 
 
A. MC Algorithm Technical Details 
Image registrations performed in the algorithm 
were executed by the open-source NiftyReg medical 
image registration software (16). Briefly, the rigid 
registration relied on a symmetric block-matching 
algorithm and least-trimmed square regression. We 
employed a 12 degrees of freedom (affine) 
transform, with a normalized mutual information 
(NMI) similarity metric and a threshold of 10% 
outlier blocks in the optimization scheme. For the 
non-rigid (deformable) b-spline registration, the 
implementation performed a three-stage approach 
each with a higher resolution (grid), utilizing NMI 
similarity with 64 bins, a spline spacing of 5 voxels 
at the full resolution. For regularization, we used a 
bending energy penalty of 0.3 to constrain non-
realistic deformations, and log of the Jacobian 
determinant penalty of 0.1. These parameters were 
optimized using a grid-search on 3 datasets.  
 
 To improve the quality of image registration, 
region-of-interest masks were created using the FSL 
FMRIB software library (17) and MeVisLab 
visualization (MeVis Medical Solutions, Version 
3.0) to constrain the registration algorithms to the 
relevant image features. One mask was constructed 
per 4D acquisition. The algorithm pipeline was 
designed to be executed by the Stanford Sherlock 
Cluster, which provides 64000 MB of memory per 
node and 16 cores per node. The pipeline was 
rewritten to accommodate parallel processing 
within the Stanford Sherlock Cluster to decrease 
lengthy runtimes. Parallelization of the MC 
algorithm was able to reduce the processing times 
approximately four-fold on average (720 minutes to 
180 minutes). 
IV. RESULTS 
A. Positional Improvement Evaluation 
Following MC, the volume overlap of the lesions 
increased significantly (p = 0.023), and the overall 
lesion remained in the same 3D position (as shown 
in Fig. 2 and 3). Table 2 expresses the average 
percentage of lesion volume that overlaps with the 
other images in the sample sequence for all eight 
patient studies. For images that exhibited poor 
positional similarity and low volume overlap 
initially (~40-60%), MC was capable of 
significantly improving the positional similarity and 
volume overlap to exceed 80% for most data sets. 
For images that possessed high-volume overlap 
prior to MC, the images post-MC either improved 
slightly or remained at relatively the same volume 
overlap, indicating that the MC algorithm does not 
cause regression in images not heavily affected by 
motion artifacts. Fig. 4 shows the improvement in 
lesion repositioning following MC.  
 
B. Image Similarity Improvement Evaluation 
The similarity analysis shows that there is an 
improvement in normalized correlation coefficients 
post-MC. Table 2 shows that motion corrected 
images have higher image similarity, meaning that 
consecutive images were able to represent similarly 
positioned anatomy with respect to time following 
MC. Significant improvement (p ≤ 0.001) in image 
similarity at two different sets of image frames (35-
39 and 55-59) within the same 4D sequence persists 
throughout the imaging acquisition and not just at 
specific windows of the 4D sequence as seen in Fig. 
5.  
C. Time-Intensity Analysis Improvement Evaluation 
MC reduces the average SSE and RMSE for all 
the generated TICs, as seen in Table 3. 
Furthermore, the R2 value also increased 
significantly following MC, indicating that the 
fitted curve for TICs experienced less noisy and 
outlier data. The fitted curves for motion corrected 
data experienced less data spikes qualitatively and a 
decreased range of intensity values, as seen in Fig. 
6. A lognormal model was used to fit our curves, as 
has been suggested to be an ideal curve fitting 
model for liver masses [REF]. 
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Figure 2. Frames from the Pre-MC imaging scan of P-01 (top) compared to their corresponding frames in the Post-MC imaging scan (bottom). 
 
 
Figure 3. Frames from the Pre-MC imaging scan of P-04 (top) compared to their corresponding frames in the Post-MC imaging scan (bottom). 
 
TABLE 2. Results of Positional Improvement and Image Similarity Evaluation  
 Average Volume Overlap 
of Liver Lesion 
Average Image Similarity by 
Normalized Cross-
Correlation (Frames 35-39) 
Average Image Similarity 
by Normalized Cross-
Correlation (Frames 55-59) 
 Pre-MC Post-MC Pre-MC Post-MC Pre-MC Post-MC 
Average 68.39% ± 
13% 
83.15% ± 
3% 
0.723 ± 0.066 0.886 ± 0.036 0.694 ± 0.057 0.862 ± 
0.049 
p-value 0.023* 0.0001*** 4.30 x 10-5 *** 
* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001 
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Figure 4. Box and whisker plot comparing Pre-MC and Post-MC average lesion volume overlap (left). Side-by-side comparison of two 
segmented lesions from neighboring frames of two different imaging studies overlaid on one another (right). The two top panels represent 
segmented lesions from P-01, while the two bottom panels represent segmented lesions from P-04. The left two panels are Pre-MC, while the 
right two panels are Post-MC. The white segmented lesion is overlapped on top of the red segmented lesion, therefore greater visualization of 
the red segmented lesion implies greater lesion displacement and poor concordance in tumor morphology between the two frames being 
compared.    
 
 
 
    
Figure 5. Box and whisker plots comparing the average normalized cross-correlation values for the Pre-MC and Post-MC imaging studies. The 
left plot represents the average normalized cross-correlation values for time frames 35-39, while the right plot represents the average 
normalized cross-correlation values for time frames 55-59 for each of the 8 patient imaging studies.
 
TABLE 3. Results of Bolus Time-Intensity Metrics Evaluation  
 Sum of Squared Errors 
(SSE) 
Root Mean Square Error 
(RMSE) 
Coefficient of Determination 
(R2) 
 Pre-MC Post-MC Pre-MC Post-MC Pre-MC Post-MC 
Average 0.472 ± 
0.394 
0.166 ± 
0.073 
0.078 ± 0.025 0.049 ± 0.012 0.861 ± 0.062 0.932 ± 
0.044 
p-value 0.065 0.018* 0.029* 
* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001 
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Figure 6. Comparison of fitted time-intensity curves at the tumor region of interest for P01 prior to MC (left) 
and after MC (right). 
 
V. DISCUSSION 
DCE-US imaging is highly susceptible to changes 
in the imaging window and transducer beam 
stemming from operator and/or subject movement 
(11). In the context of quantitative analysis of 
volumetric (3D) imaging studies for cancer 
treatment monitoring, minor changes in the 
orientation of the transducer can be problematic for 
the reliability and reproducibility of the perfusion 
parameters extracted. Studies into quantitative 
mapping of tumor vascularity have reported errors 
ranging from 6.4% to 40.3% due to millimeter-sized 
deviations in transducer positioning (20). As a 
result, we developed a MC algorithm that aims to 
mitigate the degree of misalignment found 
inherently in each pre-processed imaging study.  
 
For the first evaluation methodology, presented in 
Table 2 and Figure 4, volume overlap for a 
window series of five volumetric imaging frames 
per patient increased significantly following MC. 
Additionally, tumor morphology that previously 
differed qualitatively also improved in similarity 
with the lesions closely resembling its neighboring 
frames. This is advantageous during voxel-by-voxel 
quantification of DCE-US imaging studies for 
perfusion parameters because it reduces the 
potential for non-lesion intensity signals to interfere 
with the region-of-interest and cause the 
quantification software to misinterpret surrounding 
noise as relevant perfusion. This is highlighted in 
one case investigating the quantification of tumor 
microvascularity where more than 50% of 
acquisitions were not quantifiable due to excess 
noise caused by motion that made the lesions non-
stationary and the TICs highly sporadic (21).  
 
Image similarity comparisons using normalized 
cross correlation were employed to confirm that 
voxel intensities in one frame corresponded to those 
of the neighboring frames.  
As seen in Table 2 and Figure 5, the magnitude of 
the average image similarity per patient improved 
significantly for two different window series, 
implying that the voxel correlation between 
subsequent frames in the imaging acquisition has 
improved. With improved voxel alignment from 
frame to frame within a volumetric imaging study, 
an improvement in voxel-by-voxel perfusion 
quantification should be expected. Due to improved 
concordance and alignment between voxels going 
from frame to frame, the maximum intensity values 
in time-intensity curves should decrease because the 
interference of misaligned, non-lesion voxel signals 
in TIC quantification will be mitigated. 
Furthermore, by decreasing interference from 
misaligned voxels, the fitted curve to the time-
intensity curve should result in a better quality of 
fit, as measured by R2 and the sum of squared 
errors.  
 
For the time-intensity curve analysis, all of the 
expected observations were verified following 
generation of bolus time-intensity curves and 
quantitative metrics. Following MC for every 
patient’s imaging study, the SSE decreased (p = 
0.065), while the RMSE error decreased 
significantly (p = 0.018). The R2 value for the fitted 
curve increased significantly (p = 0.029). These 
trends highlight how the MC algorithm improves 
TIC curve fitting by decreasing the variance in the 
intensity signals of the imaging acquisition that are 
used for perfusion quantification. Additionally, for 
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some imaging acquisitions, the maximum intensity 
observed pre-MC reaches values nearly three-times 
greater than the maximum intensity observed post-
MC, as seen in Figure 6. This indicates that the MC 
algorithm is able to improve the reliability of 
quantification findings by mitigating the number of 
occurrences where non-lesion intensity values are 
interpreted as tumor perfusion, vasculature, and 
angiogenesis.  
 
The advent of DCE-US imaging in the context of 
clinically monitoring tumor angiogenesis and 
microvasculature and evaluating response to anti-
angiogenic treatment has been fueled by promising 
results observed in many preclinical and clinical 
studies investigating the utility of the imaging 
modality. Preclinical studies have been able to 
demonstrate that the vascular pathology and tumor 
microvasculature perfusion determined by CEUS 
quantification is concordant with the actual 
histopathology of the tumor (22), while clinical 
studies have successfully differentiated between 
malignant and benign tumors, as well as responding 
and non-responding tumors to anti-angiogenic 
therapy, by employing TIC analysis to measure 
kinetic properties of tumor perfusion and identify 
morphological differences between tumors (23-24). 
Having verified the qualities of our MC algorithm 
in clinical data sets, future work will aim to test our 
algorithm directly in the clinical setting and 
determine whether it has a translational effect in 
improving the assessment of tumor response to 
treatment. Parametric mapping and time-intensity 
curve analysis have been able to successfully 
characterize to a limited degree, so it is our hope 
that the MC algorithm’s ability to significantly 
decrease the poor signal-to-noise ratio within the 
lesion’s ROI, improve the similarity of images on a 
frame-to-frame basis, and elucidate the tumor’s 
morphology will translate into more accurate and 
confident prognostications of patient progress 
during cancer treatment. 
VI. CONCLUSION 
Investigations into the efficacy of 3D DCE-US 
imaging for cancer treatment monitoring have 
shown that 3D DCE-US has the potential to become 
an effective imaging modality for cancer treatment 
prognosis (1) (4) (5). However, the presence of 
motion artifacts on imaging studies severely inhibits 
the quality of quantification, thus making MC of 3D 
DCE-US imaging a crucial target for further 
investigation. This study presents and validates a 
MC algorithm with great potential for mitigating 
motion artifacts in 3D DCE-US. We demonstrate 
that the algorithm consistently generates 
improvement across a variety of different liver 
metastasis imaging acquisitions qualitatively, and 
highlight its robustness quantitatively through 
improvement in lesion volume overlap, increase in 
image similarity, and better accuracy of bolus-time 
intensity analysis. These results indicate that the 
utilization of the MC algorithm can help mitigate 
motion artifacts, thereby improving quantification 
of 3D DCE-US features and evaluation of tumor 
response to treatment and allowing physicians to 
develop personalized therapies based off treatment 
response with greater potential for recovery. 
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